These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12962030)
1. [Blood-brain barrier in multiple sclerosis: mechanisms of its breakdown and repair]. Kanda T Nihon Rinsho; 2003 Aug; 61(8):1402-8. PubMed ID: 12962030 [TBL] [Abstract][Full Text] [Related]
2. [Disruption of the blood-brain barrier in inflammatory neurological diseases]. Shimizu F; Kanda T Brain Nerve; 2013 Feb; 65(2):165-76. PubMed ID: 23399674 [TBL] [Abstract][Full Text] [Related]
3. Infiltration of inflammatory cells through brain endothelium. Couraud PO Pathol Biol (Paris); 1998 Mar; 46(3):176-80. PubMed ID: 9769913 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients. Kim HJ; Biernacki K; Prat A; Antel JP; Bar-Or A Clin Immunol; 2004 Apr; 111(1):38-46. PubMed ID: 15093550 [TBL] [Abstract][Full Text] [Related]
5. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154 [TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels. Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542 [TBL] [Abstract][Full Text] [Related]
7. [Magnetic Resonance Imaging study of the role of the blood-brain barrier in the pathogenesis of experimental allergic encephalomyelitis: application to multiple sclerosis]. Chambron J; Namer IJ; Steibel J; Gounot D; Armspach JP Bull Acad Natl Med; 1994 Dec; 178(9):1647-63; discussion 1663-5. PubMed ID: 7788436 [TBL] [Abstract][Full Text] [Related]
8. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Correale J; Villa A Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713 [TBL] [Abstract][Full Text] [Related]
9. The blood-brain barrier in cortical multiple sclerosis lesions. van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323 [TBL] [Abstract][Full Text] [Related]
10. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291 [TBL] [Abstract][Full Text] [Related]
11. How do immune cells overcome the blood-brain barrier in multiple sclerosis? Larochelle C; Alvarez JI; Prat A FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344 [TBL] [Abstract][Full Text] [Related]
12. Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis. Kraus J; Bauer R; Chatzimanolis N; Engelhardt B; Tofighi J; Bregenzer T; Kuehne BS; Stolz E; Blaes F; Morgen K; Traupe H; Kaps M; Oschmann P J Neurol; 2004 Apr; 251(4):464-72. PubMed ID: 15083294 [TBL] [Abstract][Full Text] [Related]
13. [Blood-brain barrier and blood-nerve barrier in neuroinflammatory diseases]. Maeda T; Kanda T Nihon Rinsho; 2013 May; 71(5):789-94. PubMed ID: 23777083 [TBL] [Abstract][Full Text] [Related]
14. The impact of interferon-beta treatment on the blood-brain barrier. Kraus J; Oschmann P Drug Discov Today; 2006 Aug; 11(15-16):755-62. PubMed ID: 16846804 [TBL] [Abstract][Full Text] [Related]
15. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. Prat A; Biernacki K; Antel JP J Autoimmun; 2005 Mar; 24(2):119-24. PubMed ID: 15829404 [TBL] [Abstract][Full Text] [Related]
16. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. McQuaid S; Cunnea P; McMahon J; Fitzgerald U Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657 [TBL] [Abstract][Full Text] [Related]
17. Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. Veldhuis WB; Floris S; van der Meide PH; Vos IM; de Vries HE; Dijkstra CD; Bär PR; Nicolay K J Cereb Blood Flow Metab; 2003 Sep; 23(9):1060-9. PubMed ID: 12973022 [TBL] [Abstract][Full Text] [Related]
18. Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. Steiner O; Coisne C; Cecchelli R; Boscacci R; Deutsch U; Engelhardt B; Lyck R J Immunol; 2010 Oct; 185(8):4846-55. PubMed ID: 20861356 [TBL] [Abstract][Full Text] [Related]
19. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Merrill JE; Murphy SP Brain Behav Immun; 1997 Dec; 11(4):245-63. PubMed ID: 9512813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]